Introduction
Prescription and non-prescription drug abuse and overdose is a growing problem in the United States, and is referred to as a public epidemic by the Centers for Disease Control (CDC). Prescription drug overdose death rates have more than tripled since 1990 1 . It killed an estimated 37,485 people in 2009 and is the cause of 100 deaths every day in the United Sates. Every 19 minutes a person dies from a prescription pain killer overdose. The CDC reports that today millions of Americans are addicted to opiates or prescription pain pills and "more than 12 million people reported using prescription painkillers non-medically in 2010-that is, using them without a prescription or for the feeling they cause." 2 The economic costs of prescription drug abuse are substantial; drug and alcohol problems cost the United States an estimated $276 billion a year. 3 Substance abuse results in higher healthcare expenses for injuries and illnesses; lower productivity and performance; an increase in workers' compensation and disability claims. In 2009, the misuse and abuse of prescription painkillers was responsible for more than 475,000 emergency department visits, which has nearly doubled in five years. 4 
Methods
The World Health Organization (WHO) website was used for identifying controlled substances regulations and the regulatory authorities responsible for medicines in each country. In addition, leaders in the pharmaceutical industry were contacted by email and mail in order to identify information about classification systems for controlled Schedule 2 drugs, substances, or chemicals are defined as drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence. Such drugs include amphetamines, fentanyl, and oxycodone. Schedule 2 drugs allow no refills. A new prescription must be brought into the pharmacy each month. New to this category was the recent rescheduling of hydrocodone (Vicodin) which moved from schedule 4 to schedule 2.
Schedule 3 drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Some examples are Tylenol with Codeine and Buprenorphine.
Schedule 4 drugs are defined as drugs with a low potential for abuse and a low risk of dependence. Some examples include Xanax (Alprazolam), Soma (Carisoprodol), and Valium (Diazepam). 14 Norway ranks high on the European statistics for overdoses. As shown in Figure 1 , heroin, other opioids, and methadone were the leading causes of drug-related deaths in 2011 in Norway. 
INNOVATIONS in pharmacy

Slovenia
Controlled substances are classified into three groups:
• Group I: plants and substances which are very dangerous to human health due to the severe consequences which can result from their abuse and which are not used in medicine (heroin, cocaine, opium poppy concentrate, cannabis/THC, PCP, MDMA, MDA, MDE, khat, mescaline, psilocybin, etc); • Group II: plants and substances considered highly dangerous, due to the severe consequences which can result from their abuse, and which can be used in medicine (cocaine, amphetamine, methamphetamine, opium, morphine, codeine, methadone, buprenorphine, etc.); • Group III: plants and substances of medium danger, due to the consequences which can result from their abuse, and which can be used in medicine (mostly barbiturate and non-barbiturate hypnotics and antiepileptics, benzodiazepine anxyolitics and hypnotics, and stimulants and anorectics /arylalkylamin and others/ such as: GHB and 2 C-B).
Netherlands
The 'main' drug law in the Netherlands is the Opium Act. Illegal substances are annexed to the Opium Act and divided in two schedules: substances presenting unacceptable risks and other substances:Schedule I, 'drugs presenting unacceptable risks' , is subdivided in a, b, and c:
• Ia: including among others opiates, cocaine, cannabis oil;
• Ib: Codeine;
• Ic: amphetamines and LSD.
Schedule II is subdivided in a and b:
• IIa: includes tranquillizers and barbiturates;
• IIb: includes cannabis (without the qualification of unacceptability).
The division in schedules has a real impact in the prosecution of illegal offences: penalties for offences with regard to Schedule II are considerably lower than those for Schedules I.
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Germany The Germany Narcotic Act divides the controlled substances into Schedule I, II, and III:
• Schedule I includes: "non-marketable narcotics"; these are illicit narcotics without current evidencebased medical benefit, e.g. heroin and all Ecstasytype drugs.
• Schedule II includes: "licit narcotic drugs, but not available as such on special prescription", e.g. narcotics which are used commercially for the manufacture of other products, particularly pharmaceuticals. These include, inter alia, delta-9-tetrahydrocannabinol (THC) and dexamphetamine.
• Schedule III includes: "marketable narcotic drugs available on special prescription", these are all narcotic drugs which may be prescribed by physicians, dental surgeons and veterinary surgeons for medical purposes (e.g. opium, morphine and methadone). 
Portugal Controlled substances are annexed to the main drug Decree Law 15/93 included in 6 schedules, regularly updated by decree laws.
• List 1 is divided into opiates; coca derivatives; Cannabis and derivatives.
• List 2 is divided into Hallucinogenic; Amphetamines;
Barbiturates.
• List 3 contains preparations with controlled substances.
• List 4 tranquillizers and analgesics.
• Lists 5 and 6 contain precursors. The difference between lists has an impact on the punishment of drug related crimes. • List I includes opiates and cocaine derivatives 
MIDDLE EAST
Israel
In Israel there are two major medication categories, those that can be sold in an authorized store, the authorization not being what store but that the medication must be placed at a level where minors cannot reach them, and the second category pharmacy only medications.
The former are GSL (General Sales List medications) and they are sold in small packs, and generally at higher prices than in a pharmacy and are very restricted in number. Examples are Paracetamol (Acetaminophen), some nose drops and diclofenac gel. The sales of these are very small and 99% of the population does not buy them.
The latter groups are sold only in pharmacies and only a pharmacist can hand out medications. These medications sold in the pharmacy fall into three categories:
• 1 OTC medications • 2 Prescription only medicines • 3 Regular medications with reasonable safety profiles (labelled P) • Ii Separanda (meaning to be kept apart from other medicines( to reduce mistakes the pharmacist is thus reminded by the place of the medicine that it requires greater attention when selling (Labelled S) • Iii Toxica -those medications with a small therapeutic window requiring extra special attention with dosing and advice (E.G. Digoxin) (Labelled T) • The Toxica category is also divided into Narcotic (additionally labelled This preparation can cause dependence) and non-narcotic categories • A prescription renewal for P Medications is required each month and the patient may receive three such prescriptions when visiting the physician • A prescription for S and non-narcotic T Medications is required each month and the patient may receive three such prescriptions when visiting the physician.
• A prescription for a narcotic can only be written for 10 days unless the physician stipulates why the patient should receive more EG "Patient is not mobile enough to get the medications easily and has no home help". In this case they could receive one month's supply, but never above that amount without a new prescription. The full instructions must be written so the wording " as directed" is not acceptable.
• The physician is encouraged by the pharmacist (pending an incoming law) to write the disease or reason for prescribing the medication particularly if it is a narcotic.
• All prescriptions must be written in Capital Letters or printed.
• Electronic Rx are now quite common so new Rxs can be received without much problem for the patient and thus reducing the number of forgeries.
Medicinal Marijuana is at present distributed on Rx by specialized physicians through specialized dispensaries. This is shortly to be changed to pharmacy only distribution for specially trained pharmacists. • Class A classification is limited to the most serious drugs requiring severe restrictions. The category has been described by Dr. Bob Boyd, Ministry of Health Chief Advisor, as "reserved for substances that one doesn't want to see in the country at all, and to presume that somebody in possession is either going to harm themselves or somebody else quite severely." 19 Currently thirty-seven substances are listed as Class A in the First Schedule to the Act; these include cocaine, heroin, LSD, phencyclidine (PCP), thalidomide, amphetamine substances (MDA, MMDA) and most recently methamphetamine.
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• Class B drugs, listed in the Second Schedule to the Act, are divided into three parts. Class B Part 1 (B1) drugs are generally processed substances, including opiates with both therapeutic and abuse potential (e.g. morphine), as well as cannabis preparations (resin and oil as refined and concentrated forms of cannabis have a higher potency than the natural plant. Class B Part 2 drugs are mainly stimulants with less dependence potential than B1 substances; these include amphetamine, ecstasy (MDMA) and methylphenidate (Ritalin). Class B Part 3 includes methadone, pethidine and other drugs commonly used for medical purposes. Part 3 may also list drugs not yet used in New Zealand, but classified internationally.
• There are seven categories of Class C drugs listed in the Third Schedule. The U.S. has long championed a hardline drug policy, supporting only international agreements that enforce drug prohibition and imposing on its citizens some of the world's harshest penalties for drug possession and sales. 21 Even with the hardline drug policy, America has the highest rates of cocaine and marijuana use in the world. 21 While most of the E.U. (including Holland) has more liberal drug laws than the U.S., it also has less drug use.
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Recommendations
The solution of this problem is the creation of a system that provides hurdles to abusers, but does not add additional barriers to the receipt of scheduled drugs for legitimate users. It was found that there are numerous ways to control abusable substances and it is not clear what the best system is. What is known is that each day 46 people die in this country after overdosing on prescription painkillers. 22 Is the American system truly working? In just the past year Tramadol has moved to be a controlled substance and all hydrocodone products are now narcotic substances. Are tighter regulations in the classification system working? Could the problem not be the system, but rather the doctors not cautiously prescribing these medications? Prescription painkillers are meant for end-of-care life or for short term treatment. The problem may not be the system per say, but instead how America is prescribing these medications. The United States, with about 5 percent of the world's population, is consuming 80 percent of the world's entire oxycodone supply and 99 percent of the world's hydrocodone supply.
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Here lies the problem, with tighter regulations; the people who are in pain have to suffer because of this epidemic. Bob Twillman of the American Academy of Pain Management suggests that, "If prescription drug abuse is an epidemic, then I think chronic pain may be a pandemic, because the Institute of Medicine tells us that it affects over 100 million people in the United States. So I think what we have to do is to find the kinds of solutions that really address both of these problems and don't wind up giving us what's essentially a zero sum game."
Maybe the key to success is addressing both of the problems. Many people in pain obtain their narcotic prescriptions from their primary care physicians. Often times, doctors don't really evaluate the status of the patient. Utilizing more pain scales and asking more detailed questions may lead to other questions and ultimately see that the patient maybe a drug seeker. If someone is battling chronic pain, that pain should be handled by a group of health care professionals at a pain specialist.
Electronic health records would help tremendously between doctors and pharmacists. The pharmacist has limited access to records about the patient. Thus, allowing the pharmacist to solely base judgment off of what the patient says. Many pharmacists are left to being mini "DEA agents." Trying to crack the code and see if a prescription is legitimate. A system where health care providers could communicate more efficiently and easily would allow more questions to be answered. Doctors can check a patient database before writing any prescriptions. Pharmacists can check the databases to make sure patients haven't been elsewhere. A team based approach would be more effective.
All in all, more pain management training needs to be presented in both pharmacy and medical schools. This is a topic that is brushed upon, but needs to be addressed to the fullest extent. Health care professionals would then be better rounded and more knowledgeable in the area leading to better outcomes.
